Alerts will be sent to your verified email
Verify EmailGUFICBIO
Gufic Biosciences
|
Orchid Pharma
|
Zota Health Care
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.83 % | n/a | 0.09 % |
Financials
|
|||
5 yr Average ROE
|
25.05 % | -4.13 % | -1.91 % |
5yr average Equity Multiplier
|
2.22 | 1.73 | 1.71 |
5yr Average Asset Turnover Ratio
|
1.05 | 0.45 | 0.99 |
5yr Avg Net Profit Margin
|
10.9 % | -7.02 % | -0.52 % |
Price to Book
|
5.68 | 2.91 | 16.58 |
P/E
|
49.02 | 36.97 | 0.0 |
5yr Avg Cash Conversion Cycle
|
26.94 Days | 49.11 Days | 38.95 Days |
Inventory Days
|
66.86 Days | 112.59 Days | 94.16 Days |
Days Receivable
|
128.09 Days | 91.49 Days | 55.69 Days |
Days Payable
|
163.91 Days | 201.52 Days | 89.31 Days |
5yr Average Interest Coverage Ratio
|
13.1 | -0.51 | 18.17 |
5yr Avg ROCE
|
27.25 % | 0.51 % | 1.25 % |
5yr Avg Operating Profit Margin
|
18.45 % | 10.69 % | 5.05 % |
5 yr average Debt to Equity
|
0.51 | 0.49 | 0.03 |
5yr CAGR Net Profit
|
14.26 % | n/a | n/a |
5yr Average Return on Assets
|
11.52 % | -1.77 % | -0.16 % |
Shareholdings
|
|||
Promoter Holding
|
72.51 % | 69.84 % | 59.72 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.26 % |
Change in Promoter Holding (3 Yrs)
|
-2.97 % | -20.16 % | -8.39 % |
Change in Mutual Fund Holding (3 Yrs)
|
2.36 % | 16.34 % | 0.03 % |